Search - tctmd.com

Displaying 101 - 120 of 445

Sort: Relevancy | Date

News Conference News ESC 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

Todd Neale

August 31, 2023

News Conference News ESC 2023

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

Yael L. Maxwell

August 29, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

L.A. McKeown

August 22, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News

Vaping’s Risks to CV Health Not Yet Fully Known: AHA

Caitlin E. Cox

July 17, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2023

Shelley Wood

July 03, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

Presentation Complex Coronary Cases 2023

In-Stent Restenosis: Update and Devices

Presenter: Melissa Chang

June 16, 2023

News Daily News

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Todd Neale

June 15, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

L.A. McKeown

June 06, 2023

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

Advertisement

ESC Endocarditis Guidelines Get First Update in 8 Years

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

TCTMD’s Michael O’Riordan Wins Digital Health Award

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

What’s Going to Be Hot at ESC 2023?

TCTMD’s Top 10 Most Popular Stories for July 2023

Women and Minorities Underrepresented in Heart Valve Trials

Vaping’s Risks to CV Health Not Yet Fully Known: AHA

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

TCTMD’s Top 10 Most Popular Stories for June 2023

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

In-Stent Restenosis: Update and Devices

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content